PA
HIMS icon

Proem Advisors’s Hims & Hers Health HIMS Stock Holding History

Proem Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500,000
Closed -$24.9M – 46
2025
Q2 		$24.9M Buy
500,000
+50,000
+11% +$2.26M 3.28% 9
2025
Q1 		$13.3M Hold
450,000
– – 3.99% 9
2024
Q4 		$10.9M Buy
+450,000
New +$11.1M 2.9% 17

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Proem Advisors's HIMS Position: Q1 2026 in Review

Proem Advisors increased its Hims & Hers Health (HIMS) stake by 144% in Q1 2026, buying an estimated $1.54M and bringing the position to 110,000 shares worth $2.28M. The position accounts for 0.14% of the portfolio, ranked #34.

Proem Advisors first reported a position in HIMS in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.9M in Q2 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Proem Advisors held 110,000 shares of Hims & Hers Health worth $2.28M as of Q1 2026.
  • Proem Advisors bought 65,000 Hims & Hers Health shares in Q1 2026, an estimated $1.54M.
  • Hims & Hers Health made up 0.14% of Proem Advisors's portfolio in Q1 2026, its #34 holding.
  • Proem Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 6 quarters since.
  • Proem Advisors's Hims & Hers Health position peaked at $22.9M in Q2 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Proem Advisors's 13F filing for Q1 2026, filed 13 May 2026.